1. Home
  2. DCTH vs MEI Comparison

DCTH vs MEI Comparison

Compare DCTH & MEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • MEI
  • Stock Information
  • Founded
  • DCTH 1988
  • MEI 1946
  • Country
  • DCTH United States
  • MEI United States
  • Employees
  • DCTH N/A
  • MEI N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • MEI Electrical Products
  • Sector
  • DCTH Health Care
  • MEI Technology
  • Exchange
  • DCTH Nasdaq
  • MEI Nasdaq
  • Market Cap
  • DCTH 398.2M
  • MEI 402.1M
  • IPO Year
  • DCTH N/A
  • MEI N/A
  • Fundamental
  • Price
  • DCTH $14.31
  • MEI $11.87
  • Analyst Decision
  • DCTH Strong Buy
  • MEI Hold
  • Analyst Count
  • DCTH 4
  • MEI 3
  • Target Price
  • DCTH $22.25
  • MEI $14.00
  • AVG Volume (30 Days)
  • DCTH 411.6K
  • MEI 415.1K
  • Earning Date
  • DCTH 11-08-2024
  • MEI 03-06-2025
  • Dividend Yield
  • DCTH N/A
  • MEI 4.72%
  • EPS Growth
  • DCTH N/A
  • MEI N/A
  • EPS
  • DCTH N/A
  • MEI N/A
  • Revenue
  • DCTH $22,644,000.00
  • MEI $1,087,900,000.00
  • Revenue This Year
  • DCTH $1,605.13
  • MEI N/A
  • Revenue Next Year
  • DCTH $111.67
  • MEI $5.77
  • P/E Ratio
  • DCTH N/A
  • MEI N/A
  • Revenue Growth
  • DCTH 945.91
  • MEI N/A
  • 52 Week Low
  • DCTH $3.70
  • MEI $8.54
  • 52 Week High
  • DCTH $14.47
  • MEI $22.20
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 70.27
  • MEI 50.85
  • Support Level
  • DCTH $12.14
  • MEI $11.48
  • Resistance Level
  • DCTH $12.98
  • MEI $12.31
  • Average True Range (ATR)
  • DCTH 0.77
  • MEI 0.66
  • MACD
  • DCTH 0.16
  • MEI -0.03
  • Stochastic Oscillator
  • DCTH 95.12
  • MEI 62.39

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

About MEI Methode Electronics Inc.

Methode Electronics Inc makes component and subsystem devices employing electrical, radio remote control, electronic, wireless, and sensing technologies. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles. The products manufactured in the automotive segment include overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors. Geographically, the company generates maximum revenue from North America and the rest from Europe, the Middle East & Africa (EMEA), and Asia.

Share on Social Networks: